List of SBIR/STTR awards granted to Mitotherapeutix LLC
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Mitotherapeutix LLC in June, 2021 for $253,050.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44DK129102-01 | Phase I | 253,050 | June 1, 2021 | |||||||
A STTR Phase I contract was awarded to Mitotherapeutix LLC in July, 2018 for $264,238.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41DK117760-01A1 | Phase I | 264,238 | July 1, 2018 | |||||||
A SBIR Phase II contract was awarded to Mitotherapeutix LLC in May, 2022 for $860,261.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44DK129102-02 | Phase II | 860,261 | May 1, 2022 | |||||||
A SBIR Phase I contract was awarded to Mitotherapeutix LLC in July, 2020 for $100,000.0 USD from the U.S. Department of Agriculture. | SBIR | 2020-00629 | Phase I | 100,000 | July 22, 2020 | |||||||
A STTR Phase I contract was awarded to Mitotherapeutix LLC in July, 2017 for $317,953.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41DK112429-01A1 | Phase I | 317,953 | July 5, 2017 | |||||||
A STTR Phase I contract was awarded to Mitotherapeutix LLC in April, 2023 for $273,918.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41AA030517-01A1 | Phase I | 273,918 | April 1, 2023 |
